Medicenna Therapeutics Corp Sustainability Reports

Medicenna Therapeutics Corp. is a clinical-stage immunotherapy company focused on the development of engineered cytokines called Superkines. The company designs treatments that precisely target cancer and modulate the immune system without harming healthy cells.

Sector: Manufacturing

Country: Canada

Exchange: Toronto Stock Exchange

FIGI: BBG008MPLP12

No reports are currently available in our catalogue.